COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance

European Journal of Pharmacology

Volumn 785, Issue , 2016, Pages 116-132

  Poorani, R ^a,b   Bhatt, Anant N ^a   Dwarakanath, B S ^a   Das, Undurti N ^b,c  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

^c UND Life Sciences   (United States)

Author keywords

Aspirin; Lipoxins; Nitric oxide; Polyunsaturated fatty acids; Prostaglandins; Resolvins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CARBON MONOXIDE; CHOLESTEROL; CYCLIC AMP; CYCLIC GMP; CYCLOOXYGENASE 2; CYTOKINE; DOCOSAHEXAENOIC ACID; ENZYME; ESSENTIAL FATTY ACID; G PROTEIN COUPLED RECEPTOR; HORMONE; HYDROGEN SULFIDE; ICOSAPENTAENOIC ACID; LIPOXIN; LIPOXIN A; MARESIN DERIVATIVE; NEUROTRANSMITTER; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEAR FACTOR; OMEGA 3 FATTY ACID; PHOSPHOLIPASE; POLYUNSATURATED FATTY ACID; PROSTACYCLIN; PROTECTIN DERIVATIVE; RESOLVIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITION; DIABETES MELLITUS; FATTY ACID METABOLISM; GENE; HUMAN; HYPOTHALAMUS; IMMUNOMODULATION; LOW DRUG DOSE; MEMORY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; VASODILATATION; ANIMAL; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; ASPIRIN; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; HUMANS;

EID: 84949630985     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.08.049     Document Type: Article

References (203)

1. Ambrozova, G., Pekarova, M., Lojek, A., Effect of polyunsaturated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages. Eur. J. Nutr. 49 (2010), 133–139.
2. Ariel, A., Chiang, N., Arita, M., Petasis, N.A., Serhan, C.N., Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal regulated kinase-dependent TNFalpha secretion from human T cells. J. Immunol. 170 (2003), 6266–6272.
3. Ariel, A., Li, P.L., Wang, W., Tang, W.X., Fredman, G., Hong, S., Gotlinger, K.H., Serhan, C.N., The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280 (2005), 43079–43086.
4. Arita, M., Bianchini, Francesca, Aliberti, Julio, Sher, Alan, Chiang, Nan, Hong, Song, Yang, Rong, Petasis, Nicos A., Serhan., Charles N., Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolving E1. J. Exp. Med. 201 (2005), 713–722.
5. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J.N., Petasis, N.A., Blumberg, R.S., Serhan, C.N., Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 102 (2005), 7671–7676.
6. Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., Wynshaw-Boris, A., Poli, G., Olefsky, J., Karin, M., IKK-ß links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005), 191–198.
7. Astorg, P., Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 15 (2004), 367–386.
8. Banu, J., Bhattacharya, A., Rahman, M., Kang, J.X., Fernandes, G., Endogenously produced n-3 fatty acids protect against ovariectomy induced bone loss in fat-1 transgenic mice. J. Bone Miner. Metab. 28 (2010), 617–626.
9. Bayorh, M.A., Ganafa, A.A., Eatman, D., Walton, M., Feuerstein, G.Z., Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am. J. Hypertens 18 (2005), 1496–1502.
10. Bellenger, J., Bellenger, S., Bataille, A., Massey, K.A., Nicolaou, A., Rialland, M., Tessier, C., Kang, J.X., Narce, M., High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 60 (2011), 1090–1099.
11. Berquin, I.M., Edwards, I.J., Kridel, S.J., Chen, Y.Q., Polyunsaturated fatty acid metabolism in prostate cancer. Cancer Metastasis Rev. 30 (2011), 295–309.
12. Bhavsar, P.K., Levy, B.D., Hew, M.J., Pfeffer, M.A., Kazani, S., Israel, E., Chung, K.F., Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma. Respir. Res., 11, 2010, 71.
13. Biteman, B., Hassan, I.R., Walker, E., Leedom, A.J., Dunn, M., Seta, F., Laniado-Schwartzman, M., Gronert, K., Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21 (2007), 2257–2266.
14. Bonventre, J.V., Phospholipase A2 and signal transduction. J. Am. Soc. Nephrol. 3 (1992), 128–150.
15. Calder, P.C., The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot. Essen. Fatty Acids 79 (2008), 101–108.
16. Calder, P.C., Bond, J.A., Harvey, D.J., Gordon, S., Newsholme, E.A., Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem. J. 269 (1990), 807–814.
17. Calder, P.C., Yaqoob, P., Harvey, D.J., Watts, A., Newsholme, E.A., The incorporation of fatty acids by lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem. J. 300 (1994), 509–518.
18. Calviello, G., Di Nicuolo, F., Gragnoli, S., Piccioni, E., Serini, S., Maggiano, N., Tringali, G., Navarra, P., Ranelletti, F.O., Palozza, P., n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1 alpha induction pathway. Carcinogenesis 25 (2004), 2303–2310.
19. Carlini, V.P., Perez, M.F., Salde, E., Schiöth, H.B., Ramirez, O.A., de Barioglio, S.R., Ghrelin induced memory facilitation implicates nitric oxide synthase activation and decrease in the threshold to promote LTP in hippocampal dentate gyrus. Physiol. Behav. 101 (2010), 117–123.
20. Cathcart, M.C., O'Byrne, K.J., Reynolds, J.V., O'Sullivan, J., Pidgeon, G.P., COX derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention. Biochim. Biophys. Acta 1825 (2012), 49–63.
21. Chamras, H., Ardashian, A., Heber, D., Glaspy, J.A., Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J. Nutr. Biochem. 13 (2002), 711–716.
22. Chaung, H.C., Chang, C.D., Chen, P.H., Chang, C.J., Liu, S.H., Chen, C.C., Docosahexaenoic acid and phosphatidylserine improves the antioxidant activities in vitro and in vivo and cognitive functions of the developing brain. Food Chem. 138 (2013), 342–347.
23. Chen, W., Esselman, W.J., Jump, D.B., Busik, J.V., Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 46 (2005), 4342–4347.
24. Chiang, N., Fredman, G., Backhed, F., Oh, S.F., Vickery, T., Schmidt, B.A., Serhan, C.N., Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484 (2012), 524–528.
25. Clària, J., Dalli, J., Yacoubian, S., Gao, F., Serhan, C.N., Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol. 189 (2012), 2597–2605.
26. Cominelli, F., Nast, C.C., Llerena, R., Dinarello, C.A., Zipser, R.D., Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins. J. Clin. Invest. 85 (1990), 582–586.
27. Corminboeuf, O., Leroy, X., FPR2/ALXR agonists and the resolution of inflammation. J. Med. Chem. 58 (2015), 537–559.
28. Crawford, M.A., Sinclair, A.J., Msuya, P.M., Munhambo, A., Structural lipids and their polyenoic constituents in human milk. Galli, C., Jacini, C., Pecile, A., (eds.) Dietary Lipids and Post Natal Development, 1973, New York Raven Press, 41–56.
29. Cristopher, D.B., Gilroy, D.W., Serhan, C.N., Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40 (2014), 315–327.
30. Croxtall, J.D., Choudhury, Q., Tokumoto, H., Flower, R.J., Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein-dependent activation of cPLA2 activity. Biochem. Pharmacol. 50 (1995), 465–474.
31. Dalli, J., Kraft, B.D., Colas, R.A., Shinohara, M., Fredenburgh, L.E., Hess, D.R., Chiang, N., Welty-Wolf, K.E., Choi, A.M., Piantadosi, C.A., Serhan, C.N., Proresolving lipid mediator profiles in baboon pneumonia are regulated by inhaled carbon monoxide. Am. J. Respir. Cell Mol. Biol., 2015 ahead of print.
32. Das, U.N., Beneficial effect of eicosapentaenoic acid and docosahexaenoic acid in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot. Essen. Fatty Acids 51 (1994), 207–213.
33. Das, U.N., Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Cancer Lett. 56 (1991), 235–243.
34. Das, U.N., Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot. Essen. Fatty Acids 52 (1993), 387–391.
35. Das, U.N., Beneficial action(s) of eicosapentaenoic acid/docosahexaenoic acid and nitric oxide in systemic lupus erythematosus. Med. Sci. Res. 23 (1995), 723–726.
36. Das, U.N., Oxidants, anti-oxidants, essential fatty acids, eicosanoids, cytokines, gene/ oncogene expression and apoptosis in systemic lupus erythematosus. J. Assoc. Physicians India. 46 (1998), 630–634.
37. Das, U.N., Can perinatal supplementation of long chain polyunsaturated fatty acids prevent hypertension in adult life?. Hypertension 38 (2001), e6–e8.
38. Das, U.N., A Perinatal strategy for preventing adult diseases: the role of long-chain polyunsaturated fatty acids. 2002, Kluwer Academic Publishers, Boston.
39. Das, U.N., A perinatal strategy to prevent coronary heart disease. Nutrition 19 (2003), 1022–1027.
40. Das, U.N., Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-α, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain Dev. 25 (2003), 251–261.
41. Das, U.N., Can perinatal supplementation of long-chain polyunsaturated fatty acids prevent diabetes mellitus?. Eur. J. Clin. Nutrition. 57 (2003), 218–226.
42. Das, U.N., Long-chain polyunsaturated fatty acids in memory formation and consolidation: Further evidence and discussion. Nutrition 19 (2003), 988–993.
43. Das, U.N., Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory. Nutrition 19 (2003), 62–65.
44. Das, U.N., A defect in the activity of Δ6and Δ5desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot. Essen. Fatty Acids 72 (2005), 343–350.
45. Das, U.N., A defect in the activity of Δ6and Δ5desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot. Essen. Fatty Acids 76 (2007), 251–268.
46. Das, U.N., Vagus nerve stimulation, depression and inflammation. Neuropsychopharmacology 32 (2007), 2053–2054.
47. Das, U.N., Cross talk among leukocytes, platelets, and endothelial cells and its relevance to atherosclerosis and coronary heart disease. Cur. Nutr. Food Sci. 5 (2009), 75–93.
48. Das, U.N., Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J. Inflamm. Res. 3 (2010), 143–170.
49. Das, U.N., Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Clin. Lipidol. 6 (2011), 463–489.
50. Das, U.N., Is multiple sclerosis a proresolution deficiency disorder?. Nutrition 28 (2012), 951–958.
51. Das, U.N., Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 29 (2013), 1175–1185.
52. Das, U.N., Is sepsis a pro-resolution deficiency disorder?. Med. Hypotheses 80 (2013), 297–299.
53. Das, U.N., Lipoxins, resolvins, protectins, maresins and nitrolipids and their clinical implications with specific reference to diabetes mellitus and other diseases: Part II. Clin. Lipidol. 8 (2013), 465–480.
54. Das, U.N., N-3 fatty acids, γ-linolenic acid, and antioxidants in sepsis. Crit. Care, 17, 2013, 312.
55. Das, U.N., Nutritional factors in the pathobiology of autism. Nutrition 29 (2013), 1066–1069.
56. Das, U.N., Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 42 (2013), 122–134.
57. Das, U.N., HLA-DR expression, cytokines and bioactive lipids in sepsis. Arch. Med. Sci. 10 (2014), 325–335.
58. Das, U.N., Lipoxins, resolvins, protectins, maresins and nitrolipids and their clinical implications with specific reference to cancer: Part I. Clin Lipidol. 8 (2014), 437–463.
59. Das, U.N., Cytokines, angiogenic and anti-angiogenic factors and bioactive lipids in pre-eclampsia. Nutrition 31 (2015), 1083–1095.
60. Das, U.N., Metabolic syndrome pathophysiology: the role of essential fatty acids and their metabolites. 2010, Wiley-Blackwell Publishers, Ames, IA, USA.
61. Das, U.N., Molecular basis of health and disease. 2011, Springer, New York.
62. Das, U.N., Begin, M.E., Ells, G., Horrobin, D.F., Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Rad. Biol. Med. 3 (1987), 9–15.
63. Das, U.N., Begin, M.E., Ells, G., Horrobin, D.F., Polyunsaturated fatty acids augment free radical generation in tumor-cells in vitro. Biochem. Biophys. Res. Commun. 145 (1987), 15–20.
64. Das, U.N., Puskás, L.G., Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Lipids Health Dis., 8, 2009, 61.
65. Das, U.N., Vijay Kumar, K., Krishna Mohan, I., Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J. Nutr. Med. 4 (1994), 149–155.
66. Das, U.N., Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-2 to prevent human essential hypertension. Eur. J. Clin. Nutr. 58 (2004), 195–203.
67. Das, U.N., Biological significance of essential fatty acids. J. Assoc. Physician India 54 (2006), 309–319.
68. Das, U.N., Essential fatty acids: biochemistry, physiology, and pathology. Biotech. J. 1 (2006), 420–439.
69. Das, U.N., Can essential fatty acids reduce the burden of disease(s)?. Lipids Health Dis., 7, 2008, 9.
70. Das, U.N., Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis., 10, 2011, 76.
71. Das, U.N., Madhavi, N., Effect of polyunsaturated fatty acids on drug sensitive and resistant tumor cells in vitro. Lipids Health and Dis., 10, 2011, 159.
72. Devi, G.R., Das, U.N., Rao, K.P., Rao, M.S., Prostaglandins and mutagenesis: prevention and/or reversibility of genetic damage induced by benzo (a) pyrene in the bone marrow cells of mice by prostaglandins El. Prostaglandins Leukot. Med. 15 (1984), 287–292.
73. Devi, G.R., Das, U.N., et al. Prostaglandins and mutagenesis: modification of phenytoin-induced genetic damage by Prostaglandins in lymphocyte cultures. Prostaglandins Leukot. Med. 15 (1984), 109–113.
74. Das, U.N., Devi, G.R., Rao, K.P., Rao, M.S., Prostaglandins and their precursors can modify genetic damage induced by benzo (a,) pyrene and gamma-radiation. Prostaglandins. 29 (1985), 911–920.
75. Das, U.N., Ramadevi, G., Rao, K.P., Rao, M.S., Prostaglandins can modify gamma-radiation and chemical induced cytotoxicity and genetic damage in vitro and in vivo. Prostaglandins 38 (1989), 689–716.
76. Koratkar, R., Das, U.N., Sangeetha, P.S., Ramesh, G., Padma, M., Sravan Kumar, K., Madhavi, N., Prostacyclin is a potent anti-mutagen. Prostaglandins Leukot. Essent. Fatty Acids 48 (1993), 175–184.
77. De Antueno, R., Elliot, M., Ells, G., Quiroga, P., Jenkins, K., Horrobin, D., In vivo and in vitro biotransformation of the lithium salt of gamma-linolenic acid by three human carcinomas. Br. J. Cancer 75 (1997), 1812–1818.
78. De Kock, M., Lottering, M.L., Grobler, C.J., Viljoen, T.C., Le Roux, M., Seegers, J.C., The induction of apoptosis in human cervical carcinoma (HeLa) cells by gamma-linolenic acid. Prostaglandins Leukot. Essent. Fatty Acids 55 (1996), 403–411.
79. Demetz, E., Schroll, S., Auer, K., et al. The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab. 20 (2014), 787–798.
80. Deng, B., Wang, C.-W., Arnardottir, H.H., Li, Y., Cheng, C.-Y.C., Dalli, J., Serhan, C.N., Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages. PLOS One, 9(7), 2014, e102362.
81. Dentin, R., Benhamed, F., Pégorier, J.-P., Foufelle, F., Viollet, B., Vaulont, S., Girard, J., Postic, C., Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J. Clin. Invest. 10 (2005), 2843–2854.
82. Devchand, P.R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R.L., Gronert, K., Serhan, C.N., Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense. FASEB J. 17 (2003), 652–659.
83. Di Nunzio, M., Van Deursen, D., Verhoeven, A.J., Bordoni, A., N-3 and n6 polyunsaturated fatty acids suppress sterol regulatory element binding protein activity and increase flow of non-esterified cholesterol in HepG2 cells. Br. J. Nutr. 103 (2010), 161–167.
84. Di Rosa, M., Radomski, M., Carnuccio, R., Moncada, S., Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172 (1990), 1246–1252.
85. Dobrowsky, R.T., Kamibayashi, C., Mumby, M.C., Hannun, Y.A., Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268 (1993), 15523–15530.
86. Dommels, Y.E., Haring, M.M., Keestra, N.G., Alink, G.M., Van Bladeren, P.J., Van Ommen, B., The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis 24 (2003), 385–392.
87. Duffield, J.S., Hong, S., Vaidya, V.S., Lu, Y., Fredman, G., Serhan, C.N., Bonventre, J.V., Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177 (2006), 5902–5911.
88. Dupertuis, Y.M., Meguid, M.M., Pichard, C., Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007), 427–432.
89. Esterbauer, H., Wag, G., Puhl, H., Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull. 49 (1993), 566–576.
90. Field, F.J., Born, E., Murthy, S., Mathur, S.N., Polyunsaturated fatty acids decrease the expression of sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol transport. Biochem. J. 368:Pt 3 (2002), 855–864.
91. Funahashi, H., Satake, M., Hasan, S., Sawai, H., Newman, R.A., Reber, H.A., Hines, O.J., Eibl, G., Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas 36 (2008), 353–362.
92. Ge, H., Kong, X., Shi, L., Hou, L., Liu, Z., Li, P., Gamma-linolenic acid induces apoptosis and lipid peroxidation in human chronic myelogenous leukemia K562 cells. Cell. Biol. Int. 33 (2009), 402–410.
93. Gibson, R.A., Kneebone, G.M., Fatty acid composition of human colostrums and mature breast milk. Am. J. Clin. Nutr. 34 (1981), 252–257.
94. Gilroy, D.W., Colville-Nash, P.R., Willis, D., Chivers, J., Paul-Clark, M.J., Willoughby, D.A., Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5 (1999), 698–701.
95. Gilroy, D.W., Newson, J., Sawmynaden, P., Willoughby, D.A., Croxtall, J.D., A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 18 (2004), 489–498.
96. Gilroy, D.W., New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins. Mem. Inst. Oswaldo. Cruz. 100:Suppl 1 (2005), s49–s54.
97. Gilroy, D.W., Colville-Nash, P.R., Willis, D., Chivers, J., Paul-Clark, M.J., Willoughby, D.A., Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5 (1999), 698–701.
98. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., Brady, H.R., Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164 (2000), 1663–1667.
99. González-Périz, A., Planagumà, A., Gronert, K., Miquel, R., López-Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., Rodés, J., Clària, J., Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20 (2006), 2537–2539.
100. Goppelt-Struebe, M., Rehfeldt, W., Glucocorticoids inhibit TNF alpha-induced cytosolic phospholipase A2 activity. Biochim. Biophys. Acta 1127 (1992), 163–167.
101. Gronert, K., Maheshwari, N., Khan, N., Hassan, I.R., Dunn, M., Laniado Schwartzman, M., A role for the mouse 12/15lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280 (2005), 15267–15278.
102. Guilford, W.J., Parkinson, J.F., Second generation beta-oxidation resistant 3-oxa-lipoxin A4analogs. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005), 245–250.
103. Gurzell, E.A., Teague, H., Harris, M., Clinthorne, J., Shaikh, S.R., Fenton, J.I., DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function. J. Leukoc. Biol. 93 (2013), 463–470.
104. Han, S., Koo, D., Kang, N., Yoon, W., Kang, G., Kang, H., Yoo, E., Docosahexaenoic acid alleviates atopic dermatitis by generating tregs and IL-10/TGF-β-modified macrophages via a TGF-β-dependent mechanism. J. Invest. Dermatol. 135 (2014), 1556–1564, 10.1038/jid.2014.488.
105. Han, S.C., Kang, G.J., Ko, Y.J., Kang, H.K., Moon, S.W., Ann, Y.S., Yoo, E.S., Fermented fish oil suppresses T helper 1/2 cell response in a mouse model of atopic dermatitis via generation of CD4+CD25+Foxp3+ T cells. BMC Immunol., 13, 2012, 44.
106. Han, J., Thompson, P., Beutler, B., Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172 (1990), 391–394.
107. Hannah, V.C., Ou, J., Luong, A., Goldstein, J.L., Brown, M.S., Unsaturated fatty acids down-regulate srebp isoforms 1a and 1c by two mechanisms in HEK-293 cells. J. Biol. Chem. 276 (2001), 4365–4372.
108. Harbige, L.S., Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38 (2003), 323–341.
109. Harris, W.S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L.L., Appel, L.J., Engler, M.M., Engler, M.B., Sacks, F., Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American heart association nutrition subcommittee of the council on nutrition, physical activity, and metabolism; council on cardiovascular nursing; and council on epidemiology and prevention. Circulation 119 (2009), 902–907.
110. Hashimoto, A., Hayashi, I., Murakami, Y., Sato, Y., Kitasato, H., Matsushita, R., Iizuka, N., Urabe, K., Itoman, M., Hirohata, S., Endo, H., Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. J. Rheumatol. 34 (2007), 2144–2153.
111. Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N.A., Levy, B.D., Serhan, C.N., Van Dyke, T.E., RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. FASEB J. 20 (2006), 401–403.
112. Haus, J.M., Kashyap, S.R., Kasumov, T., Zhang, R., Kelly, K.R., Defronzo, R.A., Kirwan, J.P., Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58 (2009), 337–343.
113. Hellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., Spite, M., Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25 (2011), 2399–2407.
114. Hoffman, M., A new role for gases: neurotransmission. Science, 252, 1991, 1788.
115. Holland, W.L., Bikman, B.T., Wang, L.P., Yuguang, G., Sargent, K.M., Bulchand, S., Knotts, T.A., Shui, G., Clegg, D.J., Wenk, M.R., Pagliassotti, M.J., Scherer, P.E., Summers, S.A., Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121 (2011), 1858–1870.
116. Hong, S., Gronert, K., Devchand, P., Moussignac, R.L., Serhan, C.N., Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autocoids in antiinflammation. J. Biol. Chem. 278 (2003), 14677–14687.
117. Hong, S., Lu, Y., Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury. Front. Immunol., 4, 2013, 13.
118. Horrobin, D.F., The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. Rev. Pure Appl. Pharmacol. Sci. 4 (1983), 339–383.
119. Hudert, C.A., Weylandt, K.H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C.N., Kang, J.X., Transgenic mice rich in endogenous n-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. USA 103 (2006), 11276–11281.
120. Issan, Y., Hochhauser, E., Guo, A., Gotlinger, K.H., Kornowski, R., Leshem-Lev, D., Lev, E., Pora, E., Snir, E., Thompson, C.I., Abraham, N.G., Laniado-Schwartzman, M., Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. Prostaglandins. Other. Lipid. Mediat. 100–101 (2013), 15–21.
121. Jia, Q., Lupton, J.R., Smith, R., Weeks, B.R., Callaway, E., Davidson, L.A., Kim, W., Fan, Y.Y., Yang, P., Newman, R.A., Kang, J.X., McMurray, D.N., Chapkin, R.S., Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res. 68 (2008), 3985–3991.
122. József, L., Zouki, C., Petasis, N.A., Serhan, C.N., Filep, J.G., Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. USA 99 (2002), 13266–13271.
123. Katan, M.B., Omega-6 polyunsaturated fatty acids and coronary heart disease. Am. J. Clin. Nutr. 89 (2009), 1283–1284.
124. Katoh, T., Lakkis, F.G., Makita, N., Badr, K.F., Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. Kidney Int. 46 (1994), 341–349.
125. Katsuyama, K., Shichiri, M., Kato, H., Imai, T., Marumo, F., Hirata, Y., Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology. 140 (1999), 2183–2190.
126. Knowles, R.G., Salter, M., Brooks, S.L., Moncada, S., Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun. 172 (1990), 1042–1048.
127. Kohyama, T., Liu, X., Kim, H.J., Kobayashi, T., Ertl, R.F., Wen, F.Q., Takizawa, H., Rennard, S.I., Prostacyclin analogs inhibit fibroblast migration. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2002), L428–L432.
128. Krishna Mohan, I., Das, U.N., Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot. Essen. Fatty Acids 56 (1997), 193–198.
129. Kumar, G.S., Das, U.N., Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot. Essen. Fatty Acids 50 (1994), 331–334.
130. Kunicka, J.E., Talle, M.A., Denhardt, G.H., Brown, M., Prince, L.A., Goldstein, G., Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell. Immunol. 149 (1993), 39–49.
131. Kutteh, W.H., Rainey, W.E., Carr, B.R., Glucocorticoids inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by human fetal Kupffer cells. J. Clin. Endocrinol. Metab. 73 (1991), 296–301.
132. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K., Serhan, C.N., Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2 (2001), 612–619.
133. Li, P., Oh, D.Y., Bandyopathyay, G., Lagakos, W.S., Talukdar, S., Osborn, et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat. Med. 21 (2015), 239–247.
134. Li, H., Ruan, X.Z., Powis, S.H., Fernando, R., Mon, W.Y., Wheeler, D.C., Moorhead, J.F., Varghese, Z., EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPARgamma-dependent mechanism. Kidney Int. 67 (2005), 867–874.
135. Lin, F., Yu, X., Zhang, X., Guo, Y., Huang, Y., Zhou, J., Zeng, P., Ye, D., Huang, Y., A synthetic analog of lipoxin A4 partially alleviates dexamethasone-induced fetal growth restriction in rats. Placenta 34 (2013), 941–948.
136. Liu, C.-C.F., Carlson, S.E., Rhodes, P.G., Rao, V.S., Meydrech, E.F., Increase in plasma phospholipid docosahexanoic acid and eicosapentaenoic acid as a reflection of their intake and mode of administration. Pediatr. Res. 22 (1987), 292–296.
137. Liu, P., Li, Y.S., Quartermain, D., Boutajangout, A., Ji, Y., Inhaled nitric oxide improves short term memory and reduces the inflammatory reaction in a mouse model of mild traumatic brain injury. Brain Res. 1522 (2013), 67–75.
138. Maddox, J.F., Colgan, S.P., Clish, C.B., Petasis, N.A., Fokin, V.V., Serhan, C.N., Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity. FASEB J. 12 (1998), 487–494.
139. Marcheselli, V.L., Hong, S., Lukiw, W.J., et al. Novel docosanoids inhibit brain ischemia reperfusion-mediated leukocyte infiltration and proinflammatory gene expression. J. Biol. Chem. 278 (2003), 43807–43817.
140. Mas, E., Croft, K.D., Zahra, P., Barden, A., Mori, T.A., Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 58 (2012), 1476–1484.
141. Mauer, J., Chaurasia, B., Plum, L., Quast, T., Hampel, B., Blüher, M., Kolanus, W., Kahn, C.R., Brüning, J.C., Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet., 6, 2010, e1000938.
142. Menendez, J.A., Ropero, S., Lupu, R., Colomer, R., Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression. Oncol. Rep. 11 (2004), 1241–1252.
143. Menendez, J.A., Ropero, S., Mehmi, I., Atlas, E., Colomer, R., Lupu, R., Over expression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids:a novel mechanism by which dietary fat can alter mammary tumorigenesis. Int. J. Oncol. 24 (2004), 1369–1383.
144. Mukherjee, P.K., Marcheselli, V.L., Serhan, C.N., Bazan, N.G., Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA 101 (2004), 8491–8496.
145. Nascimento-Silva, V., Arruda, M.A., Barja-Fidalgo, C., Villela, C.G., Fierro, I.M., Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase1in endothelial cells. Am. J. Physiol. Cell. Physiol. 289 (2005), C557–C563.
146. Neuhofer, A., Zeyda, M., Mascher, D., Itariu, B.K., Murano, I., Leitner, L., Hochbrugger, E.E., Fraisl, P., Cinti, S., Serhan, C.N., Stulnig, T.M., Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 62 (2013), 1945–1956.
147. Nordgren, T.M., Heires, A.J., Wyatt, T.A., Poole, J.A., LeVan, T.D., Cerutis, D.R., Romberger, D.J., Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust. Resp. Res., 14, 2013, 51.
148. Ogston, N.C., Karastergiou, K., Hosseinzadeh-Attar, M.J., Bhome, R., Madani, R., Stables, M., Gilroy, D., Flachs, P., Hensler, M., Kopecky, J., Mohamed-Ali, V., Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue. Int. J. Obes. 32 (2008), 1807–1815.
149. Okuda, Y., Kawashima, K., Sawada, T., Tsurumaru, K., Asano, M., Suzuki, S., Soma, M., Nakajima, T., Yamashita, K., Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem. Biophys. Res. Commun. 232 (1997), 487–491.
150. Osborn, Olivia, Olefsky, Jerrold M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18 (2012), 363–374.
151. Pike, L.J., Rafts defined: a report on the Keystone symposium on lipid rafts and cell function. J. Lipid. Res. 47 (2006), 1597–1598.
152. Pittner, R.A., Spitzer, J.A., Steroid hormones inhibit induction of spontaneous nitric oxide production in cultured hepatocytes without changes in arginase activity or urea production. Proc. Soc. Exp. Biol. Med. 202 (1993), 499–504.
153. Pouliot, M., Serhan, C.N., Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. J. Periodontal Res. 34 (1999), 370–373.
154. Pouliot, M., Clish, C.B., Petasis, N.A., Van Dyke, T.E., Serhan, C.N., Lipoxin A4analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 39 (2000), 4761–4768.
155. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., Ridker, P.M., C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J. Am. Med. Assoc. 286 (2001), 327–334.
156. Prescott, D., McKay, D.M., Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production. Am. J. Physiol. Gastrointest. Liver Physiol. 301 (2011), G487–G497.
157. Puzzo, D., Staniszewski, A., Deng, S.X., Privitera, L., Leznik, E., Liu, S., Zhang, H., Feng, Y., Palmeri, A., Landry, D.W., Arancio, O., Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J. Neurosci. 29 (2009), 8075–8086.
158. Qu, X., Zhang, X., Yao, J., Song, J., Nikolic-Paterson, D.J., Li, J., Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J. Pathol. 228 (2012), 506–519.
159. Radomski, M.W., Palmer, R.M., Moncada, S., Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 87 (1990), 10043–10047.
160. Rahman, M.M., Bhattacharya, A., Banu, J., Kang, J.X., Fernandes, G., Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. J. Cell. Mol. Med. 13:8B (2009), 1833–1844.
161. Richard, D., Kefi, K., Barbe, U., Bausero, P., Visioli, F., Polyunsaturated fatty acids as anti-oxidants. Pharmacol. Res. 57 (2008), 451–455.
162. Ringholz, F.C., Buchanan, P.J., Clarke, D.T., Millar, R.G., McDermott, M., Linnane, B., Harvey, B.J., McNally, P., Urbach, V., Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis. Eur. Respir. J. 44 (2014), 394–404.
163. Rodgers, K., McMahon, B., Mitchell, D., Sadlier, D., Godson, C., Lipoxin A4 modifies platelet derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am. J. Pathol. 167 (2005), 683–694.
164. Rundhaug, J.E., Simper, M.S., Surh, I., Fischer, S.M., The role of the EP receptors for prostaglandin E(2) in skin and skin cancer. Cancer Metastasis Rev., 30, 2011, 465–480.
165. Sagar, P.S., Das, U.N., Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins. Leukot. Essent. Fatty. Acids 53 (1995), 287–299.
166. Sagar, P.S., Das, U.N., Koratkar, R., Ramesh, G., Padma, M., Kumar, G.S., Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells: relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer. Lett. 63 (1992), 189–198.
167. Sailaja Devi, M.M., Das, U.N., Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro. Prostaglandins Leukot Essen. Fatty Acids 71 (2004), 309–318.
168. Sailaja, M.M.S., Das, U.N., Effect of prostaglandins against alloxan-induced diabetes mellitus. Prostaglandins Leukot Essen. Fatty Acids 74 (2006), 39–60.
169. Sailaja, P., Mani, A.M., Naveen, K.V.G., Anasuya, D.H., Siresha, B., Das, U.N., Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro. PLoS One, 9, 2014, e114766.
170. Samuelsson, B., Dahle´n, S.E., Lindgren, J.A.˚, Rouzer, C.A., Serhan, C.N., Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237 (1987), 1171–1176.
171. Schmocker, C., Weylandt, K.H., Kahlke, L., Wang, J., Lobeck, H., TiegBerg, T., Kang, J.X., Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 45 (2007), 864–869.
172. Schottelius, A.J., Giesen, C., Asadullah, K., Fierro, I.M., Colgan, S.P., Bauman, J., Guilford, W., Perez, H.D., Parkinson, J.F., An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti inflammatory profile. J. Immunol. 169 (2002), 7063–7070.
173. Schwab, J.H., Anderle, S.K., Brown, R.R., Dalldorf, F.G., Thompson, R.C., Pro- and anti- inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect. Immun. 59 (1991), 4436–4442.
174. Serhan, C.N., Chiang, N., Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics. Rheum. Dis. Clin. North Am. 30 (2004), 69–95.
175. Serhan, C.N., Dalli, J., Karamnov, S., Choi, A., Park, C.K., Xu, Z.Z., Ji, R.R., Zhu, M., Petasis, N.A., Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26 (2012), 1755–1765.
176. Serhan, C.N., Special issue on lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot. Essent. Fatty. Acids 73 (2005), 163–177.
177. Serhan, C.N., Clish, C.B., Brannon., J., Colgan., S.P., Gronert, K., Chiang, N., Anti-inflammatory lipid signals generated from dietary n_3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and n-3 PUFA therapeutic actions. J. Physiol. Pharmacol. 4 (2000), 643–654.
178. Serhan, C.N., Hong, S., Gronert, K., Colgan, S.P., Devchand, P.R., Mirick, G., Moussignac, R.L., Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med. 196 (2002), 1025–1037.
179. Serhan, C.N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S.P., Petasis, N.A., Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176 (2006), 1848–1859.
180. Shackelford, R.E., Alford, P.B., Xue, Y., Thai, S.F., Adams, D.O., Pizzo, S., Aspirin inhibits tumor necrosis factor alpha gene expression in murine tissue macrophages. Mol. Pharmacol. 52 (1997), 421–429.
181. Shaikh, S.R., Jolly, Christopher A., Chapkin, Robert S., n-3 Polyunsaturated fatty acids exert immunomodulatory effects on lymphocytes by targeting plasma membrane molecular organization. Mol. Aspects. Med. 33:1 (2012), 46–54.
182. Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 387 (1997), 569–572.
183. Skilton, M.R., Ayer, J.G., Harmer, J.A., Webb, K., Leeder, S.R., Marks, G.B., Celermajer, D.S., Impaired fetal growth and arterial wall thickening: a randomized trial of Omega-3 supplementation. Pediatrics, 129, 2012, e698.
184. Skilton, M.R., Mikkila¨, V., Wu¨rtz, P., Ala-Korpela, M., Sim, K.A., Soininen, P., Kangas, A.J., Viikari, J.S.A., Juonala, M., Laitinen, T., Lehtima¨ki, T., Taittonen, L., Kähönen, M., Celermajer, D.S., Raitakari, O.T., Fetal growth, omega-3 (n23) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The cardiovascular risk in young finns study. Am J. Clin. Nutr. 97 (2013), 58–65.
185. Sodin-Semrl, S., Spagnolo, A., Barbaro, B., Varga, J., Fiore, S., Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes. Int. J. Immunopathol. Pharmacol. 17 (2004), 15–25.
186. Sodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J., Fiore, S., Lipoxin A4inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164 (2000), 2660–2666.
187. Suresh, Y., Das, U.N., Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Essen. Fatty Acids 64 (2001), 37–52.
188. Suresh, Y., Das, U.N., Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition 19 (2003), 93–114.
189. Suresh, Y., Das, U.N., Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-3 fatty acids. Nutrition 19 (2003), 213–228.
190. Suryaprabha, P., Das, U.N., Ramesh, G., Kumar, K.V., Kumar, K.S., Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essen. Fatty Acids 43 (1991), 251–255.
191. Takano, T., Fiore, S., Maddox, J.F., Brady, H.R., Petasis, N.A., Serhan, C.N., Aspirin-triggered 15-epi-lipoxin A4and LXA4stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185 (1997), 1693–1704.
192. Terano, T., Shiina, T., Tamura, Y., Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids 31:Suppl. (1996), S301–S304.
193. Titos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., Clària, J., Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol. 187 (2011), 5408–5418.
194. Tobin, D.M., Ramakrishnan, L., TB: the Yin and Yang of lipid mediators. Curr. Opin. Pharmacol. 13 (2013), 641–645.
195. Walker, J., Dichter, E., Lacorte, G., Kerner, D., Spur, B., Rodriguez, A., Yin, K., Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock 36 (2011), 410–416.
196. Wan, M., Godson, C., Guiry, P.J., Agerberth, B., Haeggström, J.Z., Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counter regulated by lipoxin A4 and resolvin E1. FASEB J. 25 (2011), 1697–1705.
197. Wang, Y.P., Wu, Y., Li, L.Y., Zheng, J., Liu, R.G., Zhou, J.P., Yuan, S.Y., Shang, Y., Yao, S.L., Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells. J. Neuroinflamm., 8, 2011, 95.
198. Watkins, G., Martin, T.A., Bryce, R., Mansel, R.E., Jiang, W.G., Gamma linolenic acid regulates the expression and secretion of SPARC in human cancer cells. Prostaglandins Leukot. Essent. Fatty Acids 72 (2005), 273–278.
199. Wu, L., Miao, S., Zou, L.B., Wu, P., Hao, H., Tang, K., Zeng, P., Xiong, J., Li, H.H., Wu, Q., Cai, L., Ye, D.Y., Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury. J. Mol. Neurosci. 48 (2012), 185–200.
200. Xia, S., Lu, Y., Wang, J., He, C., Hong, S., Serhan, C.N., Kang, J.X., Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc. Natl. Acad. Sci. USA 2006:103 (2006), 12499–12504.
201. Xu, J., Cho, H., O'Malley, S., Park, J.H., Clarke, S.D., Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. J. Nutr. 132 (2002), 3333–3339.
202. Xu, Z., Zhao, J., Zhang, H., Ke, T., Xu, P., Cai, W., Katirai, F., Ye, D., Huang, Y., Huang, B., Spontaneous miscarriages are explained by the stress/glucocorticoid/lipoxin A4 axis. J. Immunol. 190 (2013), 6051–6058.
203. Zhang, D., Li, Y., Peng, H., Liu, H., Cheng, Q., Cheng, X., Zeng, P., Wu, P., Chen, H., Huang, Y., Ye, D., Glucocorticoids sensitize rat placental inflammatory responses via inhibiting lipoxin A4 biosynthesis. Biol. Reprod., 90, 2014, 74.